Walvax Biotechnology Soars on Regulatory Boost for Biotech Innovations
Walvax Biotechnology Co Ltd’s stock price surged by over 8% following regulatory announcements that aim to accelerate clinical trial approvals, positioning the company for sustained growth in the biotech sector.
3 minutes to read